Tarsus Pharmaceuticals, Inc. (TARS) has a market capitalization of $3.14B and trades at $73.81. The 52-week range is 38.51-85.25.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -46.4, Earnings Per Share (EPS) of $-1.59, annual revenue of $451.36M.
The stock has a beta of 0.63, operates in the Healthcare sector.
